Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2023-04-26

FDA Approved: VERSACLOZ — Supplemental Application (TruPharma LLC)

View source ↗

Summary

FDA notes a supplemental application for Versacloz (clozapine) by TruPharma LLC, indicating a labeling change or amendment to the approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VERSACLOZ (CLOZAPINE)

Snippet

SUPPL AP for VERSACLOZ (CLOZAPINE)